These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8359057)

  • 1. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated extremity perfusion with TNF-alpha and melphalan in unresectable soft tissue sarcoma. Indications, principles and technique].
    Taeger G; Ruchholtz S; Niebel W; Müller S; Nast-Kolb D
    Unfallchirurg; 2004 Jul; 107(7):619-23. PubMed ID: 15252711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
    Eigler FW; Krause U
    Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
    Hohenberger P; Bida B; Schlag PM
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():14-5. PubMed ID: 8946039
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
    Ghussen F; Nagel K
    Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
    Eroglu A; Kocaoglu H; Demirci S; Akgül H
    Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
    Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
    Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
    Rastrelli M; Campana LG; Valpione S; Tropea S; Zanon A; Rossi CR
    Int J Hyperthermia; 2016; 32(2):165-72. PubMed ID: 26608883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.
    Taeger G; Grabellus F; Podleska LE; Müller S; Ruchholtz S
    Int J Hyperthermia; 2008 May; 24(3):193-203. PubMed ID: 18392998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
    Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soft tissue tumors: indications and results of hyperthermia].
    Issels RD; Bosse D; Starck M; Abdel-Rahman S; Jauch KW; Schildberg FW; Wilmanns W
    Chirurg; 1993 Jun; 64(6):461-7. PubMed ID: 8359058
    [No Abstract]   [Full Text] [Related]  

  • 17. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
    Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
    Haier J; Hohenberger P; Beck K; Schlag PM
    Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: treatment response and clinical outcome related to changes in proliferation and apoptosis.
    Plaat BE; Molenaar WM; Mastik MF; Koudstaal J; van den Berg E; Koops HS; Hoekstra HJ
    Clin Cancer Res; 1999 Jul; 5(7):1650-7. PubMed ID: 10430064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.